Supplementary Figure 8: Third iteration of REVEALER for the drug sensitivity to a MEK-inhibitor example.
From: Characterizing genomic alterations in cancer by complementary functional associations
A) Conditional to the summary feature after the second iteration, consisting of BRAF and KRAS mutations, REVEALER finds NRAS mutations as the top hit. B) The clustered version of the same top scoring features shown in A.
